During the past decade, ICIMED Instituto de Investigación en Ciencias Médicas conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ICIMED Instituto de Investigación en Ciencias Médicas" are "Influenza" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Alzheimer's Disease" (1 trials), "Breast Cancer" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "ICIMED Instituto de Investigación en Ciencias Médicas" in a lesser frequency.

Most popular intervention types in "ICIMED Instituto de Investigación en Ciencias Médicas" are "Drug" (13 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Atezolizumab" (4 trials), "Baloxavir Marboxil" (3 trials), "Ipatasertib" (2 trials) and "Abiraterone" (1 trials). Other intervention names were less common.

The vast majority of trials in "ICIMED Instituto de Investigación en Ciencias Médicas" are 12 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "ICIMED Instituto de Investigación en Ciencias Médicas". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ICIMED Instituto de Investigación en Ciencias Médicas, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ICIMED Instituto de Investigación en Ciencias Médicas, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".